InsidersTradesSigma
DocMorris AG: insider trades · Switzerland · SIX SER
SIX:docmorris-agCH0042615283CH·SIX SERHealthcare & Pharma
Discover the full directors' dealings record of DocMorris AG, a publicly traded company based in Switzerland. Shares are quoted on CH CH, under the authority of SIX SER. Operating in the Healthcare & Pharma sector, DocMorris AG has logged 82 reports. The latest transaction was reported on 22 May 2026 (Purchase). Among the most active insiders: Anonymous (Non-executive member of the board of directors). The full history is accessible without an account.
82
Insider Decl.
0
Thresholds
€6m
67 ops.
Buy Volume
€2m
15 ops.
Sell Volume
Financial data
Last declaration on 22 May 2026
Declarations82 total
Executives●Purchase19SIX
A
Anonymous (an executive member of the board of directors / member of senior management)an executive member of the board of directors / member of senior management€9,5321,321 shares@ €7.2214100.0% of flow
SIX:https://www.ser-ag.com/en/resources/notifications-market-participants/management-transactions.html#/transaction-details/T1Q5M00027·
Ideal exit: 16 Feb 2027 (T+270)
Executives●Purchase0SIX
A
Anonymous (Executive member of the board of directors / member of senior management)Executive member of the board of directors / member of senior management€9,5321,321 shares@ €7.216
SIX:T1Q5M00027·
Ideal exit: 16 Feb 2027 (T+270)
Executives●Purchase14SIX
A
Anonymous (a non-executive member of the board of directors)a non-executive member of the board of directorsCHF 217,88426,700 shares@ CHF 8.162751.3% of flow
SIX:https://www.ser-ag.com/en/resources/notifications-market-participants/management-transactions.html#/transaction-details/T1Q4M00053·
Ideal exit: 17 Jan 2027 (T+270)
Executives●Purchase18SIX
A
Anonymous (Non-executive member of the board of directors)Non-executive member of the board of directors€217,88426,700 shares@ €8.16044.2% of flow
SIX:T1Q4M00053·
Ideal exit: 17 Jan 2027 (T+270)
Executives●Purchase14SIX
A
Anonymous (a non-executive member of the board of directors)a non-executive member of the board of directorsCHF 207,13028,000 shares@ CHF 7.400248.7% of flow
SIX:https://www.ser-ag.com/en/resources/notifications-market-participants/management-transactions.html#/transaction-details/T1Q4K00024·
Ideal exit: 15 Jan 2027 (T+270)
Executives●Purchase18SIX
A
Anonymous (Non-executive member of the board of directors)Non-executive member of the board of directors€207,13028,000 shares@ €7.39754.0% of flow
SIX:T1Q4K00024·
Ideal exit: 15 Jan 2027 (T+270)
Executives●Purchase18SIX
A
Anonymous (Executive member of the board of directors / member of senior management)Executive member of the board of directors / member of senior management€694160 shares@ €4.33820.0% of flow
SIX:T1Q3O000A8·
Ideal exit: 19 Dec 2026 (T+270)
Executives●Purchase18SIX
A
Anonymous (Non-executive member of the board of directors)Non-executive member of the board of directors€117,18125,000 shares@ €4.68722.3% of flow
SIX:T1Q3J00010·
Ideal exit: 14 Dec 2026 (T+270)
Executives●Purchase18SIX
A
Anonymous (Non-executive member of the board of directors)Non-executive member of the board of directors€89,32219,800 shares@ €4.51121.7% of flow
SIX:T1Q3J00028·
Ideal exit: 14 Dec 2026 (T+270)
Executives●Purchase18SIX
A
Anonymous (Executive member of the board of directors / member of senior management)Executive member of the board of directors / member of senior management€19,0684,269 shares@ €4.46660.9% of flow
SIX:T1Q3J00069·
Ideal exit: 14 Dec 2026 (T+270)
Executives●Purchase18SIX
A
Anonymous (Executive member of the board of directors / member of senior management)Executive member of the board of directors / member of senior management€10,1232,000 shares@ €5.06130.5% of flow
SIX:T1Q3J00044·
Ideal exit: 14 Dec 2026 (T+270)
Executives●Purchase0SIX
A
Anonymous (Executive member of the board of directors / member of senior management)Executive member of the board of directors / member of senior management€7,1831,124 shares@ €6.3903
SIX:T1PCG00060·
Ideal exit: 12 Sept 2026 (T+270)
Executives●Purchase0SIX
A
Anonymous (Executive member of the board of directors / member of senior management)Executive member of the board of directors / member of senior management€6,4571,250 shares@ €5.1659
SIX:T1PBL00047·
Ideal exit: 18 Aug 2026 (T+270)
Executives●Purchase0SIX
A
Anonymous (Non-executive member of the board of directors)Non-executive member of the board of directors€117,82820,000 shares@ €5.8914
SIX:T1PAN00011·
Ideal exit: 20 Jul 2026 (T+270)
Executives●Purchase0SIX
A
Anonymous (Executive member of the board of directors / member of senior management)Executive member of the board of directors / member of senior management€21,6053,400 shares@ €6.3543
SIX:T1P9Q00013·
Ideal exit: 23 Jun 2026 (T+270)
Executives●Purchase0SIX
A
Anonymous (Executive member of the board of directors / member of senior management)Executive member of the board of directors / member of senior management€10,6981,754 shares@ €6.099
SIX:T1P9Q00021·
Ideal exit: 23 Jun 2026 (T+270)
Executives●Purchase0SIX
A
Anonymous (Executive member of the board of directors / member of senior management)Executive member of the board of directors / member of senior management€15,7882,500 shares@ €6.3152
SIX:T1P9P00049·
Ideal exit: 22 Jun 2026 (T+270)
Executives●Purchase0SIX
A
Anonymous (Executive member of the board of directors / member of senior management)Executive member of the board of directors / member of senior management€10,1081,550 shares@ €6.5215
SIX:T1P9G00048·
Ideal exit: 13 Jun 2026 (T+270)
Executives●Purchase0SIX
A
Anonymous (Executive member of the board of directors / member of senior management)Executive member of the board of directors / member of senior management€12,7031,950 shares@ €6.5142
SIX:T1P9B00023·
Ideal exit: 8 Jun 2026 (T+270)
Executives●Purchase0SIX
A
Anonymous (Executive member of the board of directors / member of senior management)Executive member of the board of directors / member of senior management€35,7575,300 shares@ €6.7465
SIX:T1P6N00032·
Ideal exit: 20 Mar 2026 (T+270)
Executives●Purchase0SIX
A
Anonymous (Non-executive member of the board of directors)Non-executive member of the board of directors€51,6857,000 shares@ €7.3836
SIX:T1P6A00013·
Ideal exit: 7 Mar 2026 (T+270)
Executives●Purchase0SIX
A
Anonymous (Executive member of the board of directors / member of senior management)Executive member of the board of directors / member of senior management€20,6172,500 shares@ €8.2469
SIX:T1P6500021·
Ideal exit: 2 Mar 2026 (T+270)
Executives●Purchase0SIX
A
Anonymous (Non-executive member of the board of directors)Non-executive member of the board of directors€55,2066,000 shares@ €9.201
SIX:T1P5S00033·
Ideal exit: 22 Feb 2026 (T+270)
Executives●Sale0SIX
A
Anonymous (Non-executive member of the board of directors)Non-executive member of the board of directors€1,09289 shares@ €12.2672
SIX:T1P5M00093·
Executives●Purchase0SIX
A
Anonymous (Non-executive member of the board of directors)Non-executive member of the board of directors€68,1307,076 shares@ €9.6284
SIX:T1P5M00077·
Ideal exit: 16 Feb 2026 (T+270)
25 of 82 declarations
About DocMorris AG
DocMorris AG is a European digital health and online pharmacy group listed on the SIX Swiss Exchange (SMI/SPI) in Switzerland. The company was founded in 1993 and developed from a pharmaceutical distribution background into a digital platform focused on access to medicines, healthcare advice, and related services. Its registered office and business management headquarters are in Frauenfeld, Switzerland, reflecting its status as a Swiss-incorporated company. The group operates several e-commerce pharmacies for medical and pharmaceutical products and also provides professional health care services. Its product and service offering includes prescription medicines, over-the-counter drugs, and consumer health categories such as beauty and personal care. Strategically, DocMorris is positioning itself as a broader digital health ecosystem rather than a traditional online retailer. Its stated vision is to connect patients, doctors, pharmacies, and health insurers on a single platform, thereby expanding the company’s role beyond transactional pharmacy sales into recurring digital health services. From a competitive standpoint, DocMorris is one of the better-known pure-play online pharmacy operators in Europe. It combines a strong consumer brand with a multi-country operating footprint across Germany, the Netherlands, Spain, France, Portugal, and Switzerland. This geographic spread supports diversification, but it also exposes the company to country-specific regulation, reimbursement frameworks, and the pace of digital adoption in pharmacy and healthcare. For equity investors, that means the company’s growth profile depends not only on customer acquisition and retention, but also on regulatory execution and operational scalability. Recent developments point to a clear strategic reset toward profitability and technology-led differentiation. In 2025, DocMorris continued to emphasize qualitative growth and operational efficiency, while in 2026 it announced a partnership with Google to accelerate an AI-powered health platform. Management highlighted four focus areas: an AI health companion, an AI-enhanced online pharmacy, operational efficiency, and cloud/data security. The group also announced the closure of its Ludwigshafen site by the end of June 2026, with logistics to be integrated into its highly automated Heerlen facility. Management reaffirmed its target of reaching EBITDA break-even during 2026 and free cash flow break-even during 2027. Overall, DocMorris remains a growth-oriented healthcare technology and pharmacy platform listed in Switzerland, with improving strategic clarity but execution still central to the investment case.
